Authors: Mee, SL Chaminade, C Delaporte, C Markovits, J Saucier, JM Jacquemin-Sablon, A

Citation: Sl. Mee et al., Cellular resistance to the antitumor DNA topoisomerase II inhibitor S16020-2: Importance of the N-[2(dimethylamino)ethyl] carbamoyl side chain, MOLEC PHARM, 58(4), 2000, pp. 709-718

Authors: Belmokhtar, CA Torriglia, A Counis, MF Courtois, Y Jacquemin-Sablon, A Segal-Bendirdjian, E

Citation: Ca. Belmokhtar et al., Nuclear translocation of a leukocyte elastase inhibitor/elastase complex during staurosporine-induced apoptosis: Role in the generation of nuclear L-DNase II activity, EXP CELL RE, 254(1), 2000, pp. 99-109

Authors: Vincent, BRD Mousset, S Jacquemin-Sablon, A

Citation: Brd. Vincent et al., Cysteine control over glutathione homeostasis in Chinese hamster fibroblasts overexpressing a gamma-glutamylcysteine synthetase activity, EUR J BIOCH, 262(3), 1999, pp. 873-878

Authors: Khelifa, T Rene, B Le Mee, S Lambert, B Saucier, JM Markovits, J Jacquemin-Sablon, H Jacquemin-Sablon, A

Citation: T. Khelifa et al., Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblastswith human topoisomerase II alpha cDNA: Selective restoration of the sensitivity to DNA religation inhibitors, CANCER RES, 59(19), 1999, pp. 4927-4936

Authors: Jacquemin-Sablon, A

Citation: A. Jacquemin-sablon, P53 inhibitor, protector of the patient?, B CANCER, 86(11), 1999, pp. 894-895